-

Reducing Costs and Fortifying Innovation Can, and Must, Coexist for the Millions of Americans Living With Chronic Disease

WASHINGTON--(BUSINESS WIRE)--Today Partnership to Fight Chronic Disease Chair Ken Thorpe released the following statement on the Reduced Costs and Continued Cures Act:

"The Partnership to Fight Chronic Disease commends Representatives Scott Peters (D-CA) and Kurt Schrader (D-OR) for their leadership in introducing the Reduced Costs and Continued Cures Act and co-sponsors Representatives Kathleen Rice (D-NY), Stephanie Murphy (D-FL) and Lou Correa (D-CA) for their support. The bill includes welcome provisions that will save patients money at the pharmacy counter -- most notably, an out-of-pocket cap on Medicare drug spending -- without cutting off access to life-saving treatments.

“This bill is a great improvement over other proposals and it preserves choice among treatment options, unlike the Lower Prescription Drug Costs Now Act, which would curtail access to critical medicines today and stifle the development of tomorrow’s treatments and cures.

“PFCD encourages lawmakers to continue pursuing reforms that reduce out-of-pocket drug costs, as such efforts will increase medication adherence and improve patients' health. We look forward to the opportunity to work with policymakers on this important and ongoing discussion.”

The Partnership to Fight Chronic Disease (PFCD) is an international coalition of patient, provider, community, business and labor groups, and health policy experts, committed to raising awareness of the number one cause of death, disability and rising health care costs: chronic disease.

Contacts

Jennifer Burke
301-801-9847
Jennifer.Burke@fightchronicdisease.org

More News From Partnership to Fight Chronic Disease

Advancing Health Equity, Improving Health Outcomes for All Could Save U.S. $3.8 Trillion

WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) today released new data and analysis on the economic impact of achieving health equity in chronic disease outcomes through 2031. The analysis found that a total of $3.8 trillion in costs could be saved by empowering people with chronic conditions to achieve recommended health outcomes, specifically $2.7 trillion in medical costs and $1.1 trillion in less absenteeism over 10 years. The data assessed people aged 18 and o...

Latest Legislation Still Falls Short for Patients

WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) released the following statement today in response to the Senate’s passage of the Inflation Reduction Act of 2022: “PFCD has long stood for comprehensive and sustainable solutions that protect both overall health outcomes and pocketbooks of people living with one or more chronic conditions. While this legislation is a solid step in a better direction for those who rely on insulin and reach the new catastrophic threshol...

Latest Prescription Drug Price Negotiation Draft Takes Two Steps Back for Seniors

WASHINGTON--(BUSINESS WIRE)--The Partnership to Fight Chronic Disease (PFCD) released the following statement today regarding the Prescription Drug Pricing Reform proposal aiming to lower drug prices through government negotiation under Medicare: “More than half of U.S. adults are living with at least one chronic condition and four in ten adults live with two or more. For people with Medicare coverage, chronic disease prevalence is even higher with millions depending on medicines and needing he...
Back to Newsroom